KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Total Current Liabilities (2016 - 2026)

Pacific Biosciences Of California has reported Total Current Liabilities over the past 16 years, most recently at $72.8 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 9.85% year-over-year to $72.8 million; the TTM value through Dec 2025 reached $72.8 million, up 9.85%, while the annual FY2025 figure was $72.8 million, 9.85% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $72.8 million at Pacific Biosciences Of California, up from $63.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $271.4 million in Q2 2023 and troughed at $33.7 million in Q1 2021.
  • A 5-year average of $105.1 million and a median of $72.8 million in 2025 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: crashed 74.44% in 2021 and later soared 335.46% in 2023.
  • Year by year, Total Current Liabilities stood at $71.7 million in 2021, then skyrocketed by 267.23% to $263.3 million in 2022, then crashed by 63.91% to $95.0 million in 2023, then plummeted by 30.23% to $66.3 million in 2024, then rose by 9.85% to $72.8 million in 2025.
  • Business Quant data shows Total Current Liabilities for PACB at $72.8 million in Q4 2025, $63.2 million in Q3 2025, and $59.8 million in Q2 2025.